News
09-08-2011, 10:10 AM
The 2nd September issue of the journal Molecular Cell has published a discovery that opens the door for the development of more effective treatment strategies for aggressive breast cancers associated with EZH2, an enzyme that promotes the estrogen receptor-negative aggressive breast cancer, which remains unresponsive to current treatment strategies...
More... (http://www.medicalnewstoday.com/articles/234106.php)
More... (http://www.medicalnewstoday.com/articles/234106.php)